Marek Ciszewski, JD | Chief Financial Officer

Marek Ciszewski, J.D., has built a career investing in, financing and building biopharma companies through an extensive network of relationships across Wall Street and the biopharma industry. Prior to becoming the founding CFO of NImmune, Mr. Ciszewski held the position of Senior Vice President of Investor Relations and Corporate Communications at Coherus Biosciences and before that, led Financial Strategy, Investor Relations and Corporate Development at Landos Biopharma, Lantern Pharma, Epirus Biopharmaceuticals and Verastem Oncology. Before entering the biopharma industry, Mr. Ciszewski spent 18 years in the financial industry, most recently as the Global Head of Equity Research at BMO Global Asset Management, one of the world’s largest asset managers. Mr. Ciszewski received a Juris Doctor degree from Chicago-Kent School of Law and dual B.Sc. degrees in Finance and Economics from DePaul University.